Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients

BACKGROUND AND OBJECTIVES: Belatacept is a first-in-class, selective co-stimulation blocker recently approved for the prophylaxis of organ rejection in adult kidney transplant recipients. The objective of this study was to report the pharmacokinetics, pharmacodynamics, and immunogenicity of belatace...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Shen, Jinshan, Townsend, Robert, You, Xiaoli, Shen, Yun, Zhan, Ping, Zhou, Zexun, Geng, Dong, Wu, Dianna, McGirr, Nadia, Soucek, Kathleen, Proszynski, Elizabeth, Pursley, Janice, Masson, Eric
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2013
Soggetti:
Original Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899455/
https://ncbi.nlm.nih.gov/pubmed/24217983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-013-0153-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi